Literature DB >> 16726756

The effects of xylazine and alpha-adrenoreceptor antagonists on bovine uterine contractility in vitro.

J C Ko1, W H Hsu, L E Evans.   

Abstract

The effects of alpha-adrenoreceptor antagonists prazosin (alpha-1), yohimbine (alpha-2), and idazoxan (alpha-2) on xylazine-induced bovine uterine contractility were tested in vitro. Uterine strips from proestrous/estrous and diestrous cows were mounted in tissue baths containing Tyrode's solution. Changes in uterine contractility were measured by strain gauge. The following results were observed: 1) Xylazine increased uterine contractility in a dose dependent manner (cumulative concentrations: 10(-8), 3x10(-8), 10(-7), 3x10(-7) and 10(-6)M). 2) Idazoxan (10(-8), 10(-7) and 10(-6)M) and yohimbine (10(-6), 10(-5) and 10(-4)M) antagonized uterine contractility induced by xylazine in a dose-dependent manner. Idazoxan was approximately 50 to 100 times more potent than yohimbine. 3) Prazosin (10(-5)M) did not alter the effect of xylazine on uterine contractility. These results suggested that xylazine-induced uterine contractility in the cyclic cow is directly mediated by myometrial alpha-2 adrenoreceptors.

Entities:  

Year:  1990        PMID: 16726756     DOI: 10.1016/0093-691x(90)90537-4

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  3 in total

1.  Identification of functional alpha-adrenoceptor subtypes in the bovine female genital tract during different phases of the oestrous cycle.

Authors:  G Re; P Badino; R Odore; C Zizzadoro; P Ormas; C Girardi; C Belloli
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

2.  Chemical capture of free-ranging cattle: immobilization with xylazine or medetomidine, and reversal with atipamezole.

Authors:  J M Arnemo; N E Søli
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

3.  Assessing the Impact of Capture on Wild Animals: The Case Study of Chemical Immobilisation on Alpine Ibex.

Authors:  Francesca Brivio; Stefano Grignolio; Nicoletta Sica; Stefano Cerise; Bruno Bassano
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.